CAV1 and lung cancer: In order to examine the clinical potential of caveolin-1 as a liquid based biomarker for radio-resistance in lung cancer, we have made an attempt to demonstrate that caveolin-1 could be used as liquid based biomarker to predict radio-resistance in cancer patients.